Diabetes, Obesity and Metabolism

Defects in insulin action in chronic heart failure
pp. 203-212(10)
Authors: Doehner, Wolfram; Anker, Stefan D.; Coats, Andrew J. S.

Fatty acids and insulin secretion
pp. 213-221(9)
Authors: Amery, Caroline M.; Nattrass, Malcolm

Regulation of the angiotensin AT1 receptor by hypercholesterolaemia
pp. 223-228(6)
Authors: Nickenig, Georg; Wassmann, Sven; Böhm, Michael

Energy metabolism and substrates oxidative patterns in type 2 diabetic patients treated with sulphonylurea alone or in combination with metformin
pp. 229-235(7)
Authors: Avignon, A.; Lapinski, H.; Rabasa-Lhoret, R.; Caubel, C.; Boniface, H.; Monnier, L.

Erythrocyte insulin receptor tyrosine kinase activity is increased in glyburide-treated patients with type 2 diabetes in good glycaemic control
pp. 237-241(5)
Authors: Santos, R.F.; Nomizo, R.; Oliveira, E.; Ursich, M.; Wajchenberg, B.; Reaven, G.M.; Azhar, S.

Preliminary study of oral polylactide microcapsulated insulin in vitro and in vivo
pp. 243-250(8)
Authors: Ma, X.Y.; Pan, G.M.; Lu, Z.; Hu, J.S.; Bei, J.Z.; Jia, J.H.; Wang, S.G.

Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes
pp. 251-256(6)
Authors: Pavlović, D.; Kocić, R.; Kocić, G.; Jevtović, T.; Radenković, S.; Mikić, D.; Stojanović, M.; Djordjević, P.B.

News and views
pp. 257-262(6)